Riskpilot← Back to searchSign inGet full accessGLOPPEN TANNHELSE AS
ASActiveOrg 922421536Nordstrandsvegen 13, 6823 SandaneDental practice care activities · NACE 8623Est. 20192 employees
Revenue 2024
NOK 3,8M
+9% vs 2023
EBITDA margin
6.3%
-24% vs 2023
Equity ratio
60.9%
Financial strength
Net profit 2024
NOK 160K
-23% vs 2023
| Revenue | NOK 3,8M | +9% |
| EBITDA | NOK 240K | -24% |
| Net profit | NOK 160K | -23% |
| Total assets | NOK 1,7M | +13% |
| Equity | NOK 1M | +19% |
| Employees | 2 | — |
Legal name
GLOPPEN TANNHELSE AS
Org number
922421536
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
20. mars 2019
Share capital
NOK 1 000 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Tannlegepraksis med sal av dertilhøyrande varer og tenester.
Address
Nordstrandsvegen 13, 6823 Sandane
Phone
+4757004000
Email
post@gloppentannhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 655 | 2 972 | 2 704 | 3 493 | 3 816 |
| Staff expenses | −1 006 | −1 182 | −751 | −1 348 | −1 532 |
| EBITDA | 186 | 222 | −69 | 317 | 240 |
| Depreciation & amort. | −105 | −105 | −83 | −72 | −57 |
| EBIT | 81 | 117 | −152 | 245 | 182 |
| Net financials | −45 | −26 | −33 | −38 | −17 |
| Profit before tax | 36 | 91 | −185 | 208 | 165 |
| Tax | −0 | −0 | −0 | −0 | 5 |
| Net profit | 36 | 91 | −185 | 208 | 160 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 893 | 1 906 | 1 660 | 1 480 | 1 669 |
| Equity | 743 | 833 | 648 | 856 | 1 016 |
| Long-term debt | 911 | 763 | 615 | 236 | 5 |
| Short-term debt | 240 | 309 | 396 | 389 | 647 |
| Total debt | 1 151 | 1 072 | 1 012 | 625 | 653 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20202024
Equity ratio
60.9%
This company
38.2%
Market median
+59% vs market
20202024
Return on equity
15.8%
This company
18.4%
Market median
+14% vs market
20202024
Net profit margin
4.2%
This company
8.1%
Market median
-48% vs market
20202024
Asset turnover
2.29×
This company
1.12×
Market median
+104% vs market
20202024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KR Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GLOPPEN TANNHELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristen Reikvam Ravnestad | Chief Executive Officer | 0 companies |
| Ingunn Reikvam Ravnestad | Board of Directors | 0 companies |